Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

321.45 +0.43 (+0.13%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,288,678
Open 321.00
Bid (Size) 320.72 (1)
Ask (Size) 321.97 (1)
Prev. Close 321.02
Today's Range 319.58 - 323.67
52wk Range 225.28 - 324.75
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
The Best Stocks to Invest $20,000 in Right Now
These healthcare giants have plenty of room left to run. 
Via The Motley Fool
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
These companies have the therapies to boost revenue for a decade. 
Via The Motley Fool

Performance

YTD
+12.39%
+12.39%
1 Month
+12.49%
+12.49%
3 Month
+2.41%
+2.41%
6 Month
+14.64%
+14.64%
1 Year
+40.85%
+40.85%

More News

Read More
3 Gene Editing Stocks to Buy Now OR You’ll Be Kicking Yourself Later
Via InvestorPlace
7 Cream-of-the-Crop Stocks to Buy Today
Via InvestorPlace
Healthcare Sector Is Lagging As We Enter 2022 Earnings Season
Via Talk Markets
The Latest Analyst Ratings for Vertex Pharmaceuticals
Via Benzinga
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years
Via Benzinga
5 Reasons to Buy Vertex Pharmaceuticals Now
Via The Motley Fool
3 Dirt Cheap Stocks to Buy in January
Via The Motley Fool
Better Biotech Buy: Bluebird Bio or CRISPR Therapeutics?
Via The Motley Fool
BP Stock, Baidu Lead 5 Stocks Near Buy Points With Big Growth Potential
Via Investor's Business Daily
3 Smart Stocks to Buy if a Recession Is on the Way
Via The Motley Fool
The Best Stocks to Invest $5,000 In Right Now
Via The Motley Fool
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
Via The Motley Fool
Incyte Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
Via Investor's Business Daily
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Via The Motley Fool
3 Unstoppable Stocks to Keep Buying in 2023
Via The Motley Fool
Vertex Pharmaceuticals Stock Meets 80-Plus Relative Strength Rating Benchmark
Via Investor's Business Daily
7 Biotech Stocks That Will Make You Rich in 10 Years
Via InvestorPlace
Vertex to Announce Fourth Quarter and Full Year 2022 Financial Results on February 7
From Vertex Pharmaceuticals Incorporated
Via Business Wire
3 Biopharma Stocks That Could Help Make You a Fortune
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023
Via Benzinga
2 Stocks Down More Than 25% to Buy Right Now
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023
Via Benzinga
5 Potentially Explosive Stocks to Buy in 2023
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.